Samra Turajlić, Director of the Cancer Research UK Manchester Institute, Consultant Oncologist at The Christie and Professor at the University of Manchester, shared on LinkedIn:
“Calling medical students at the University of Manchester, University of Leeds and University of St Andrews.
We’re recruiting for an exciting fully funded Manchester Cancer Research Centre MB-PhD project in our lab, combining AI, cancer immunology and patient-derived tumour models to identify new therapeutic vulnerabilities and better understand responses to immunotherapy.
A great opportunity for medical students interested in cancer research, computational biology and experimental science!
Application deadline: 15 March 2027
Please get in touch if you’re interested, and do share with anyone who might be!
Find out more and apply here.”
About the MB-PhD Project
The project, titled “AI-guided functional modelling of tumour-immune interactions to discover therapeutic vulnerabilities” , will combine computational and experimental approaches to study why some patients respond to cancer immunotherapy while others do not.
Students will use multimodal machine learning, tumour molecular data, immune-cell biology and patient-derived cancer models to identify and experimentally test tumour-immune dependencies associated with treatment response or resistance. The initial research focus will include renal cell carcinoma and/or melanoma.
The project is led by Samra Turajlić, alongside Magnus Rattray, Jon Lim and Kevin Litchfield, and is connected to the MANIFEST immunotherapy research programme. Applications close on 15 March 2027, with the programme scheduled to begin in September 2027.
You can also read: